Drug Type Small molecule drug |
Synonyms EXEL-0999, XL 999 |
Action inhibitors, antagonists |
Mechanism AXL inhibitors(AXL receptor tyrosine kinase inhibitors), FGFRs antagonists(Fibroblast growth factor receptors antagonists), FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Promyelocytic Leukemia | Phase 2 | United States | 01 May 2006 | |
Relapse multiple myeloma | Phase 2 | United States | 01 Feb 2006 | |
Recurrent ovarian cancer | Phase 2 | United States | 01 Jan 2006 | |
Metastatic Colorectal Carcinoma | Phase 2 | United States | 01 Dec 2005 | |
Metastatic Renal Cell Carcinoma | Phase 2 | United States | 01 Dec 2005 | |
Non-Small Cell Lung Cancer | Phase 2 | United States | 01 Dec 2005 | |
Recurrent Non-Small Cell Lung Cancer | Phase 2 | United States | 01 Dec 2005 | |
Non-small cell lung cancer stage IIIB | Phase 1 | United States | 01 Aug 2007 | |
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 01 Nov 2004 | |
Neoplasms | Phase 1 | United States | - |
Phase 2 | 79 | elwaftuuwj(xluilueelt) = vpvkqfptdf khnbnmbiud (ycxymtmysf ) | - | 20 Jun 2007 | |||
Phase 1 | 15 | awcgmrhbhw(dnfhqohnru) = nrwxucviho nkaqtsbyvl (uvugstwbcb ) View more | - | 20 Jun 2006 |